跳至主要内容
临床试验/NCT01236807
NCT01236807已完成不适用

MR INFORM - a Randomized Non-inferiority Multicenter Trial Comparing MR Perfusion Imaging and Fractional Flow Reserve (FFR) to Guide Management of Patients With Stable Coronary Artery Disease

King's College London1 个研究点 分布在 1 个国家目标入组 915 人开始时间: 2010年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
915
试验地点
1
主要终点
Occurence of major adverse cardiac events (MACE)

研究概览

简要总结

The purpose of this study is to determine if MR Perfusion Imaging is non-inferior to coronary angiography with measurement of Fractional Flow Reserve (FFR) in guiding management of patients with stable chest pain.

  • All patients will undergo an MR Perfusion Imaging test.
  • Further management will be guided by the result of the cardiac MRI in half of the patients (chosen by random).
  • The other half will undergo coronary angiography with measurement of FFR. The result of this test alone will guide their further management. The result of the initial MR Perfusion test will not be available to the treating doctors of this group.
  • All patients will receive optimal medical therapy (OMT)
  • All patients will undergo follow-up to find out if they have any relevant heart related events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Angina pectoris CCS class II and III and either
  • •≥2 cardiovascular risk factors
  • •or positive exercise treadmill test
  • •Signed written informed consent
  • •age: at least 18 years

排除标准

  • •contraindication to MR
  • •contraindication to adenosine infusion
  • •inability to lie supine for 60 minutes
  • •previous Coronary Artery Bypass Grafts
  • •revascularization within the previous 6 months
  • •cardiac arrhythmias (atrial fibrillation, >20 ectopic beats/min)
  • •poor renal function (eGFR <30ml/min)
  • •body weight > 140kg or waist perimeter > 95cm
  • •known allergy to contrast media

研究组 & 干预措施

MR Inform

Active Comparator

Management guided by the result of the MR perfusion scan. Possible intervention: coronary artery revascularization.

干预措施: MR perfusion guidance (Procedure)

FFR Inform

Active Comparator

Management guided by the result of FFR measurement. Possible intervention: coronary artery revascularization.

干预措施: FFR guidance (Procedure)

结局指标

主要结局

Occurence of major adverse cardiac events (MACE)

时间窗: 1year

Composite of all cause death, myocardial infarction and repeat revascularisation.

次要结局

  • changes in LV volumes and function(1 year)
  • Individual MACE(1 year)
  • Other adverse events(1 year)
  • Course of symptoms (angina, breathlessness)(1 year)
  • Cost comparison(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eike Nagel

Global Chief Investigator

King's College London

研究点 (1)

Loading locations...

相似试验